| El currículum oculto TS Torres, J Torres Ediciones Morata, 2005 | 2107 | 2005 |
| Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a … Y Li, X Wang, DM Blau, MT Caballero, DR Feikin, CJ Gill, SA Madhi, ... The Lancet 399 (10340), 2047-2064, 2022 | 577 | 2022 |
| Respiratory syncytial virus seasonality: a global overview P Obando-Pacheco, AJ Justicia-Grande, I Rivero-Calle, ... The Journal of infectious diseases 217 (9), 1356-1364, 2018 | 326 | 2018 |
| Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease Nature genetics 42 (9), 772-776, 2010 | 318 | 2010 |
| Respiratory syncytial virus vaccination during pregnancy and effects in infants SA Madhi, FP Polack, PA Piedra, FM Munoz, AA Trenholme, EAF Simões, ... New England Journal of Medicine 383 (5), 426-439, 2020 | 304 | 2020 |
| Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children JA Herberg, M Kaforou, VJ Wright, H Shailes, H Eleftherohorinou, ... Jama 316 (8), 835-845, 2016 | 300 | 2016 |
| Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics NI Mazur, F Martinón-Torres, E Baraldi, B Fauroux, A Greenough, ... The Lancet Respiratory Medicine 3 (11), 888-900, 2015 | 281 | 2015 |
| Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 262 | 2019 |
| Respiratory syncytial virus prefusion F protein vaccine in older adults A Papi, MG Ison, JM Langley, DG Lee, I Leroux-Roels, F Martinon-Torres, ... New England Journal of Medicine 388 (7), 595-608, 2023 | 238 | 2023 |
| Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis MJ de Castro, J Pardo-Seco, F Martinón-Torres Clinical Infectious Diseases 60 (11), 1611-1619, 2015 | 222 | 2015 |
| The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination SR Parikh, H Campbell, JA Bettinger, LH Harrison, HS Marshall, ... Journal of Infection 81 (4), 483-498, 2020 | 186 | 2020 |
| Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo … PC Richmond, HS Marshall, MD Nissen, Q Jiang, KU Jansen, ... The Lancet infectious diseases 12 (8), 597-607, 2012 | 175 | 2012 |
| Heliox therapy in infants with acute bronchiolitis F Martinon-Torres, A Rodriguez-Nunez, JM Martinon-Sanchez Pediatrics 109 (1), 68-73, 2002 | 166 | 2002 |
| Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening … NP Boeddha, LJ Schlapbach, GJ Driessen, JA Herberg, I Rivero-Calle, ... Critical care 22, 1-13, 2018 | 157 | 2018 |
| Role of monocytes/macrophages in Covid-19 pathogenesis: implications for therapy J Gómez-Rial, I Rivero-Calle, A Salas, F Martinon-Torres Infection and Drug Resistance, 2485-2493, 2020 | 128 | 2020 |
| Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta … S Zhang, LZ Akmar, F Bailey, BA Rath, M Alchikh, B Schweiger, ... The Journal of infectious diseases 222 (Supplement_7), S680-S687, 2020 | 125 | 2020 |
| Rotavirus vaccination in Europe: drivers and barriers N Parez, C Giaquinto, C Du Roure, F Martinon-Torres, V Spoulou, ... The Lancet infectious diseases 14 (5), 416-425, 2014 | 117 | 2014 |
| Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project) I Rivero-Calle, J Pardo-Seco, P Aldaz, DA Vargas, E Mascarós, ... BMC infectious diseases 16, 1-8, 2016 | 110 | 2016 |
| RSV prevention in all infants: which is the most preferable strategy? S Esposito, B Abu Raya, E Baraldi, K Flanagan, F Martinon Torres, ... Frontiers in immunology 13, 880368, 2022 | 109 | 2022 |
| Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders A Gómez-Carballa, X Bello, J Pardo-Seco, F Martinón-Torres, A Salas Genome Research 30 (10), 1434-1448, 2020 | 109 | 2020 |
